Moderna
MRNA
#275
Rank
S$113.09 B
Marketcap
S$283.27
Share price
-0.47%
Change (1 day)
674.82%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -S$3.92 Billion

According to Moderna 's latest financial reports the company's current earnings are S$2.21 Billion. In 2025 the company made an earning of -S$3.53 Billion, an increase over its 2024 earnings that were of -S$4.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$3.92 Billion11.22%
2025 -S$3.53 Billion-23.03%
2024 -S$4.58 Billion-8.22%
2023 -S$4.99 Billion-140.65%
2022 S$12.27 B-27.81%
2021 S$16.99 B-1911.15%
2020 -S$0.94 Billion44.7%
2019 -S$0.65 Billion28.63%
2018 -S$0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.48 B-960.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$19.83 B-609.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$9.82 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-S$60.6 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.36 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.43 B-136.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-S$0.21 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA